We are live on
!
Find out more
JBIO
Jade Biosciences
JBIO
JBIO
78 hedge funds and large institutions have $79.6M invested in Jade Biosciences in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
37% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 19
0.14% more ownership
Funds ownership: 2.98% → 3.12% (+0.14%)
0% more funds holding
Funds holding: 78 → 78 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
0% less capital invested
Capital invested by funds: $79.9M → $79.6M (-$382K)
52% less call options, than puts
Call options by funds: $76K | Put options by funds: $159K
Holders
78
Holders Change
–
Holders Change %
0%
% of All Funds
1.05%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
26
Reduced
19
Closed
9
Calls
$76K
Puts
$159K
Net Calls
-$83K
Net Calls Change
-$2.07M
Top Buyers
| 1 |
CCC
Cable Car Capital
San Francisco,
California
|
+$1.48M |
| 2 |
AI
Allostery Investments
Stamford,
Connecticut
|
+$1.43M |
| 3 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$1.34M |
| 4 |
Blackstone Inc
New York
|
+$1.14M |
| 5 |
DAM
Deltec Asset Management
New York
|
+$421K |
Top Sellers
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.28M |
| 2 |
PCM
Prelude Capital Management
New York
|
-$290K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$258K |
| 4 |
Morgan Stanley
New York
|
-$219K |
| 5 |
VAM
Vazirani Asset Management
New York
|
-$199K |
